Medpace Holdings (MEDP) Metrics: History & Chart

Medpace Holdings, Inc.(MEDP)

Medical - Diagnostics & Research · Cincinnati, OH

$618.06+1.62 (+0.26%)

Delayed quote: Sep 17, 2026, 3:50 PM EDT

About Medpace Holdings, Inc.

Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.

Cincinnati, OH

6,500 employees

www.medpace.com

Healthcare / Medical - Diagnostics & Research

Sector: Healthcare
Industry: Medical - Diagnostics & Research
CEO: August James Troendle

View full financials

Third-Party DCF Estimate (FMP)	$401.33
Price Gap vs Third-Party Estimate	-31.69%

7D Total Return	-0.64%
30D Total Return	-1.58%
YTD Total Return	+4.61%
1Y Total Return	+18.07%
3Y Total Return	+110.31%
5Y Total Return	+206.28%
10Y Total Return	+1885.48%
15Y Total Return	N/A
20Y Total Return	N/A

2026	+4.61%
2025	+69.05%
2024	+8.38%
2023	+44.31%
2022	-2.40%
2021	+56.35%
2020

CAGR TTM	+18.09%
CAGR 3Y	+28.12%
CAGR 5Y	+25.09%
CAGR 10Y	+34.83%
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	34.42
PE Ratio Avg TTM	34.88
PE Ratio Avg 3Y	33.53
Current VS TTM Avg	-1.31%
Current VS 3Y Avg	+2.65%
Current VS 5Y Avg	+4.83%

All Metrics

MEDP Valuation Metrics

MEDP Stock Price Metrics

MEDP Dividend Metrics

MEDP Growth Rate Metrics

MEDP Discounted Cash Flow Metrics

MEDP Returns By Period

MEDP Yearly Returns

MEDP Average Annual Returns By Period (CAGR)

MEDP Revenue Metrics

MEDP PE Ratio Metrics

MEDP PS Ratio Metrics

MEDP PB Ratio Metrics

MEDP Price to Free Cash Flow Ratio Metrics

MEDP Debt to Equity Ratio Metrics

MEDP PEG Ratio Metrics

MEDP FCF Yield

MEDP Earnings Yield

MEDP EBITDA Yield

MEDP OCF Yield

MEDP EV/EBIT Ratio Metrics

MEDP EV/EBITDA Ratio Metrics

MEDP EV/Assets Ratio Metrics

MEDP EV/Sales Ratio Metrics

MEDP Current Ratio Metrics

MEDP Quick Ratio Metrics

MEDP ROIC Metrics

MEDP Return on Assets Metrics

MEDP Return on Equity Metrics

MEDP Net Profit Margin Metrics

MEDP Gross Profit Margin Metrics

MEDP Tax Rate Metrics

PS Ratio	6.07
PS Ratio Avg TTM	6.19
PS Ratio Avg 3Y	5.72
Current VS TTM Avg	-1.88%
Current VS 3Y Avg	+6.04%
Current VS 5Y Avg	+12.02%

PB Ratio	38.95
PB Ratio Avg TTM	45.39
PB Ratio Avg 3Y	19.92
Current VS TTM Avg	-14.18%
Current VS 3Y Avg	+95.54%
Current VS 5Y Avg	+135.55%

PFCF Ratio	23.04
PFCF Ratio Avg TTM	22.12
PFCF Ratio Avg 3Y	22.69
Current VS TTM Avg	+4.15%
Current VS 3Y Avg	+1.53%
Current VS 5Y Avg	+2.22%

Debt/Equity Ratio	0.28
Debt/Equity Ratio Avg TTM	0.48
Debt/Equity Ratio Avg 3Y	0.33
Current VS TTM Avg	-42.00%
Current VS 3Y Avg	-16.87%
Current VS 5Y Avg	-20.95%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	4.34%
FCF Yield Avg TTM	4.63%
FCF Yield Avg 3Y	4.55%
Current VS TTM Avg	-6.36%
Current VS 3Y Avg	-4.53%
Current VS 5Y Avg	-4.67%

Earnings Yield	2.91%
Earnings Yield Avg TTM	2.93%
Earnings Yield Avg 3Y	3.09%
Current VS TTM Avg	-0.79%
Current VS 3Y Avg	-5.84%
Current VS 5Y Avg	-7.67%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	28.31
Ev/Ebit Ratio Avg TTM	28.64
Ev/Ebit Ratio Avg 3Y	28.22
Current VS TTM Avg	-1.16%
Current VS 3Y Avg	+0.32%
Current VS 5Y Avg	+2.10%

Ev/Ebitda Ratio	27.02
Ev/Ebitda Ratio Avg TTM	27.18
Ev/Ebitda Ratio Avg 3Y	26.47
Current VS TTM Avg	-0.60%
Current VS 3Y Avg	+2.08%
Current VS 5Y Avg	+4.89%

Ev/Assets Ratio	8.03
Ev/Assets Ratio Avg TTM	8.09
Ev/Assets Ratio Avg 3Y	6.72
Current VS TTM Avg	-0.70%
Current VS 3Y Avg	+19.47%
Current VS 5Y Avg	+39.88%

Ev/Sales Ratio	5.94
Ev/Sales Ratio Avg TTM	6.09
Ev/Sales Ratio Avg 3Y	5.62
Current VS TTM Avg	-2.42%
Current VS 3Y Avg	+5.78%
Current VS 5Y Avg	+10.83%

Current Ratio	0.73
Current Ratio Avg TTM	0.66
Current Ratio Avg 3Y	0.71
Current VS TTM Avg	+10.33%
Current VS 3Y Avg	+2.90%
Current VS 5Y Avg	+1.62%

Quick Ratio	0.73
Quick Ratio Avg TTM	0.66
Quick Ratio Avg 3Y	0.71
Current VS TTM Avg	+10.33%
Current VS 3Y Avg	+2.90%
Current VS 5Y Avg	+1.62%

ROIC	77.00%
ROIC Avg 3Y	50.75%
ROIC Avg 5Y	35.27%
Current VS 3Y Avg	+51.74%
Current VS 5Y Avg	+118.31%
Current VS 10Y Avg	+223.95%

ROA	23.89%
ROA Avg TTM	6.13%
ROA Avg 3Y	5.46%
Current VS TTM Avg	+289.86%
Current VS 3Y Avg	+337.41%
Current VS 5Y Avg	+374.58%

ROE	113.29%
ROE Avg TTM	135.73%
ROE Avg 3Y	72.08%
Current VS TTM Avg	-16.53%
Current VS 3Y Avg	+57.18%
Current VS 5Y Avg	+98.08%

Net Profit Margin	17.67%
Net Profit Margin Avg TTM	17.11%
Net Profit Margin Avg 3Y	17.39%
Current VS TTM Avg	+3.26%
Current VS 3Y Avg	+1.62%
Current VS 5Y Avg	+5.41%

Gross Profit Margin	28.76%
Gross Pft Margin Avg TTM	28.99%
Gross Pft Margin Avg 3Y	29.44%
Current VS TTM Avg	-0.80%
Current VS 3Y Avg	-2.32%
Current VS 5Y Avg	-1.29%

Tax Rate	19.98%
Tax Rate Avg 3Y	17.36%
Tax Rate Avg 5Y	14.64%
Current VS 3Y Avg	+15.07%
Current VS 5Y Avg	+36.43%
Current VS 10Y Avg	+14.38%